forty four What's more, anergic cells Generally retain the next susceptibility to apoptosis Except if anti-apoptotic proteins including BCL2 are overexpressed, as is the case for CLL cells.forty five In fact, most key therapeutic advancements happening in the final 10 years are associated with the inhibition of BCR and BCL2-mediated signaling.Di se